racemetirosine has been researched along with Skin Neoplasms in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böni, R | 1 |
| Steinert, H | 1 |
| Huch Böni, R | 1 |
| Von Schulthess, GK | 1 |
| Meyer, J | 1 |
| Dummer, R | 1 |
| Burg, G | 1 |
| Westera, G | 1 |
1 other study available for racemetirosine and Skin Neoplasms
| Article | Year |
|---|---|
Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.
Topics: Adult; Aged; alpha-Methyltyrosine; Cells, Cultured; Enzyme Inhibitors; Female; Fibroblasts; Humans; | 1997 |